$60.4 Million is the total value of Norwest Venture Partners XIV, LP's 2 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IMPL | Impel NeuroPharma, Inc. | $37,480,000 | +37.6% | 3,077,198 | 0.0% | 62.06% | +97.3% | |
| OPEN | Sell | Opendoor Technologies, Inc. | $22,915,000 | -61.4% | 1,116,185 | -66.7% | 37.94% | -44.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-10-27
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Opendoor Technologies, Inc. | 4 | Q3 2021 | 100.0% |
| Impel NeuroPharma, Inc. | 2 | Q3 2021 | 62.1% |
View Norwest Venture Partners XIV, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Dave Inc./DE | February 14, 2023 | 18,645,614 | 5.7% |
| IMPEL NEUROPHARMA INC | August 10, 2021 | 3,077,198 | 13.8% |
View Norwest Venture Partners XIV, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2021-10-27 |
| 13F-HR | 2021-08-10 |
| SC 13G | 2021-08-10 |
| 4 | 2021-04-29 |
| 4 | 2021-04-26 |
| 3 | 2021-04-22 |
| 13F-HR | 2021-04-21 |
| 13F-HR | 2021-02-16 |
View Norwest Venture Partners XIV, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.